Updated
Updated · The Daily Beast · Jun 24
Cheung Blasts Lieu Over Trump Health Rumors Tied to 79-Year-Old Drug Recipient
Updated
Updated · The Daily Beast · Jun 24

Cheung Blasts Lieu Over Trump Health Rumors Tied to 79-Year-Old Drug Recipient

3 articles · Updated · The Daily Beast · Jun 24

Summary

  • Steven Cheung publicly insulted Rep. Ted Lieu after the California Democrat suggested Donald Trump may have skipped a Capitol bill-signing ceremony because of illness or drug side effects.
  • Lieu tied his questions to a Stat report that a single 79-year-old, high-profile patient received Eli Lilly's investigational obesity drug retatrutide through the FDA's compassionate-use pathway.
  • The White House denied that Trump was the patient, though spokesman Kush Desai initially declined to answer Stat before later dismissing the claim and attacking the reporting.
  • Trump, who turns 80 next month, was described in the report as obese at 238 pounds after gaining 14 pounds in the past year, a detail fueling scrutiny over whether he could qualify for the drug.

Insights

What are the true risks of a 'miracle' obesity drug that can cause abnormal skin sensations?
Who is responsible for managing misinformation surrounding powerful new experimental drugs?
How does the 'compassionate use' system decide who gets access to revolutionary but unapproved drugs?